Arrhythmias & electrophysiology

Identification of recurrent atrial fibrillation using natural language processing applied to electronic health records

Eur Heart J Qual Care Clin OutcomesPublished Diagnostic accuracy study

Authors' conclusion

When compared with a code-based approach alone, this study's high-performing automated NLP method identified significantly more patients with recurrent AF.

Study context

Population
Adults with new-onset atrial fibrillation (AF) initiating rhythm control therapy (ablation, cardioversion or antiarrhythmic medication)
Participants
22,970 adults
Comparison
Natural language processing (NLP) algorithm vs code-based algorithm for identifying AF recurrence
Outcome
Identification of recurrent AF episodes
Follow-up
12 months after initiating rhythm control therapy
Methodological details2 US integrated healthcare delivery systems
  • 2 US integrated healthcare delivery systems

Performance

As reported in the abstract

AF recurrence within 12 months after starting rhythm control therapy, by site (site 1, site 2)
Test or modelAblation, site 1Ablation, site 2Cardioversion, site 1Cardioversion, site 2Antiarrhythmic medication, site 1Antiarrhythmic medication, site 2
NLP60.7%69.9%64.5%73.7%49.6%55.5%

NLP

Ablation, site 160.7%
Ablation, site 269.9%
Cardioversion, site 164.5%
Cardioversion, site 273.7%
Antiarrhythmic medication, site 149.6%
Antiarrhythmic medication, site 255.5%

Further findings

NLP algorithm performance vs physician-adjudicated reference standard

F-scores, sensitivity and specificity all above 0.90 at both sites

Parts of this Brief are withheld: the automatic checks could not confirm them against the abstract.

Original publication

Identification of recurrent atrial fibrillation using natural language processing applied to electronic health records. Eur Heart J Qual Care Clin Outcomes. Published 30 March 2023. doi:10.1093/ehjqcco/qcad021

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.